Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hugh R Barrett

Showing results (31-40 of 143) with videos related to

Pageof 15
Sort By:
Current Opinion in Lipidology|April 27, 2013
Dietary fatty acids and lipoprotein metabolism: new insights and updatesEsther M M Ooi, Theodore W K Ng, Gerald F Watts, et al.
Nutrients|June 5, 2015
Effect of dietary Fatty acids on human lipoprotein metabolism: a comprehensive updateEsther M M Ooi, Gerald F Watts, Theodore W K Ng, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2002
Triglyceride-rich lipoproteins from subjects with type 2 diabetes do not demonstrate increased binding to biglycan, a vascular proteoglycanLisa R Tannock, Katherine L Olin, P Hugh R Barrett, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 12, 2002
Metabolism of apoA-I as lipid-free protein or as component of discoidal and spherical reconstituted HDLs: studies in wild-type and hepatic lipase transgenic rabbitsPatrick Kee, Kerry-Anne Rye, John L Taylor, et al.
The American Journal of Clinical Nutrition|February 26, 2010
Effects of atorvastatin and n-3 fatty acid supplementation on VLDL apolipoprotein C-III kinetics in men with abdominal obesityDick C Chan, Minh N Nguyen, Gerald F Watts, et al.
Obesity Research|April 12, 2003
Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndromeDick C Chan, Gerald F Watts, P Hugh R Barrett, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 9, 2002
Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulationShirya Rashid, P Hugh R Barrett, Kristine D Uffelman, et al.
Clinical Chemistry|May 25, 2002
Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesityDick C Chan, Gerald F Watts, P Hugh R Barrett, et al.
Metabolism: Clinical and Experimental|July 30, 2002
Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentrationDick C Chan, Gerald F Watts, Trevor G Redgrave, et al.
Clinical Science (London, England : 1979)|October 8, 2014
Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial stateDick C Chan, Annette T Y Wong, Jing Pang, et al.
Pageof 15

Showing results (31-40 of 143) with videos related to

Sort By:
Pageof 15
Current Opinion in Lipidology|April 27, 2013
Dietary fatty acids and lipoprotein metabolism: new insights and updatesEsther M M Ooi, Theodore W K Ng, Gerald F Watts, et al.
Nutrients|June 5, 2015
Effect of dietary Fatty acids on human lipoprotein metabolism: a comprehensive updateEsther M M Ooi, Gerald F Watts, Theodore W K Ng, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2002
Triglyceride-rich lipoproteins from subjects with type 2 diabetes do not demonstrate increased binding to biglycan, a vascular proteoglycanLisa R Tannock, Katherine L Olin, P Hugh R Barrett, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 12, 2002
Metabolism of apoA-I as lipid-free protein or as component of discoidal and spherical reconstituted HDLs: studies in wild-type and hepatic lipase transgenic rabbitsPatrick Kee, Kerry-Anne Rye, John L Taylor, et al.
The American Journal of Clinical Nutrition|February 26, 2010
Effects of atorvastatin and n-3 fatty acid supplementation on VLDL apolipoprotein C-III kinetics in men with abdominal obesityDick C Chan, Minh N Nguyen, Gerald F Watts, et al.
Obesity Research|April 12, 2003
Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndromeDick C Chan, Gerald F Watts, P Hugh R Barrett, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 9, 2002
Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulationShirya Rashid, P Hugh R Barrett, Kristine D Uffelman, et al.
Clinical Chemistry|May 25, 2002
Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesityDick C Chan, Gerald F Watts, P Hugh R Barrett, et al.
Metabolism: Clinical and Experimental|July 30, 2002
Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentrationDick C Chan, Gerald F Watts, Trevor G Redgrave, et al.
Clinical Science (London, England : 1979)|October 8, 2014
Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial stateDick C Chan, Annette T Y Wong, Jing Pang, et al.
Pageof 15